Search Weight Loss Topics:

Page 801«..1020..800801802803..810820..»

Home » Page 801

Global Weight Loss and Management Product Market report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Weight Loss and Management Product Market. This high end strategy based market specific Global Weight Loss and Management Product Market report presentation renders a thorough presentation of the market, evaluating it in terms of a range of parameters comprising market size and dynamics, dominant and popular trends, market share, investment planning, pricing strategies and driver based review that collectively lead to steady and long term growth in the Global Weight Loss and Management Product Market.

Get a sample of the report at: https://www.orbisresearch.com/contacts/request-sample/4813948

Based on unbiased and uncompromising research mediated by research experts, Global Weight Loss and Management Product Market is a route towards thumping growth and unparalleled industry returns through the forecast span, 2020-2025. For best reader comprehension, report analysts are if the opinion that the Global Weight Loss and Management Product Market is likely to witness modest growth of xx million USD in 2020, proceeding to reach over xx million USD by 2025, clocking a CAGR of xx.

The major players covered in Weight Loss and Management Product are:

Atkins NutritionalsNutrisystemHerbalife International of AmericaBiosynergyNestleGSK (GlaxoSmithKline)VivusKraftKellogg CoQUAKERPro DieticGelesisWeight Watchers InternationalLaboratoire PYCNOWHerbalife LtdUSANA Health Sciences IncSlimming World

Global Weight Loss and Management Product Market by Type:

Meal ReplacementsDiet PillsOther Weight Loss Supplements

Global Weight Loss and Management Product Market by Application:

Fitness Centers and Health ClubsCommercial Slimming CentersHospital Health CenterOnline Weight Loss ProgramsOthers

Read complete report at: https://www.orbisresearch.com/reports/index/global-and-united-states-weight-loss-and-management-product-market-2020-by-company-type-and-application-forecast-to-2025

Regional Overview: Global Weight Loss and Management Product Market

The report offers in-depth assessment of the growth and other aspects of the Weight Loss and Management Product market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)South America (Brazil, Argentina, Colombia)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

COVID-19 Specific Analysis

Make an enquiry before buying this report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/4813948

Need to Invest in The Report

Global Weight Loss and Management Product Market Dynamics

About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: +1 (972)-362-8199; +91 895 659 5155

Read the original:
Global Weight Loss and Management Product Market 2020 Industry Trends, Forecast 2025 (Covid-19 Impact) Analysis By Top Vendors- Atkins Nutritionals...

Read More..

Acai (pronounced ah-sigh-ee) berries are one of the healthiest berry varieties in the world along with blueberries, strawberries, raspberries and others. They are about 1-inch (2.5-cm) round that grow on acai palms in the Amazon rainforests. Their dark purple skin and yellow flesh cover a large seed, while the pits are similar to those of apricots and olives.

Technically acai berries are drupes but are still considered a part of the berry family. They are high in antioxidants, vitamins and minerals that are necessary for the body and are also known to aid weight loss, reduce bad cholesterol, and promote a healthy heart.

Acai berries are usually soaked to soften their outer skin and mashed to form a dark purple paste. The shelf-life of fresh Acai berries is a small window, hence these are largely exported in pured or powder form to add to meals, smoothies and more.

However, one must exercise caution when buying the canned pulp off the shelves at the supermarket as these might contain high levels of sugar used as preservatives, which in turn is counter-productive if youre looking to adopt a healthy lifestyle. a pre-processed pulp, check the ingredient label and make sure it doesnt have added ingredients.

Acai berries are also used in health supplements for added health benefits and to promote holistic health, improve immunity and also aid in fighting other lifestyle diseases including diabetes.

How to make an acai bowl?

Blend unsweetened frozen acai pure with water or milk and make a smoothie-like base to be used as toppings. Other sliced fruits and berries, chia seeds can also be added to make a healthy acai bowl recipe.

Granola or cereal can be used as a base too, however, do check its nutritional value and the calories count before going ahead with one.

Acai bowls can also be made using acai powder by blending it with a smoothie recipe.

Are acai berries used in beauty products?

According to WebMD.com, Some cosmetics and beauty products include acai oil because of its antioxidants. Acai oil may be a safe alternative to other tropical oils used in beauty products, such as facial and body creams, anti-aging skin therapies, shampoos, and conditioners. When acai oil is processed and stored long-term, the antioxidant levels remain high.

Acai berries against Covid-19

Canadian researchers are investigating the acai berry, a popular superfood, as a treatment to prevent Covid-19s most severe symptoms.

University of Toronto scientists Michael Farkouh and Ana Andreazza, who have studied the berrys effect on inflammation responses for nearly five years, are researching how it can be used to fight Covid-19.

Its a long shot, Farkouh told AFP. But acai berries are cheap and easily accessible for everyone, as well as safe, so it was worth trying.

The duo enrolled around 580 patients who have tested positive for coronavirus in Canada and Brazil, where the berry is natively grown. Results of the 30-day study are expected to be released at the end of 2020.

Follow more stories on Facebook and Twitter

Visit link:
National Nutrition Week: What are Acai berries, how to make acai bowls and can acai berries fight C... - Hindustan Times

Read More..

Growing evidence shows that COVID-19 survivors can suffer from long-term health effects, not least heart-related complications. New research published in the Journal of the American Medical Association shows that many people who recover from the virus have heart inflammation (myocarditis). Of 100 survivors in the study, 78 had evidence of previous heart inflammation, and 60 showed ongoing inflammation at the time of observation.

This medical complication should worry us all. As of August 25, 2020, there were more than 23 million cases of the disease worldwide, 16 million recoveries, and more than 800,000 deaths. Using the JAMA study as a benchmark, we could conjecture that around ten million of those survivors have heart inflammation, implying a massive increase in the burden of non-communicable diseases (NCDs).

NCDs were already killing far too many people before the pandemic arrived. In 2016, 54% of 56.9 million total deaths were due to at least one of the ten leading causes of deaths, starting with ischemic heart disease (the narrowing of blood vessels) and then stroke both of which are NCDs of the heart.

Myocarditis is a serious condition with life-threatening consequences. When the heart is inflamed, its ability to pump blood is reduced, and it may beat irregularly. In either case, the supply of blood reaching other parts of the body is reduced, raising the likelihood of stroke and other conditions.

Myocarditis is a serious condition with life-threatening consequences.

Image: REUTERS/Marco Bello

Moreover, several NCDs are themselves risk factors for COVID-19. According to the World Health Organization, the elderly and people with pre-existing medical conditions such as asthma, diabetes, obesity, cancer, sickle cell disease, and coronary artery disease appear to be more prone to severe illness as a result of the virus.

Obesity is a major public-health problem globally, and tends to increase the risk for many other NCDs. Based on 2016 estimates, in 140 of 192 countries, at least 10% of the population is considered obese (compared to 36% in the United States, 28% in South Africa and the United Kingdom, 22% in France, 20% in Italy, and 9% in Nigeria). These obesity statistics may be a factor in the relative severity of COVID-19 across countries, helping to explain why some high-income countries have higher COVID morbidity rates than low- and middle-income countries.

The interplay between the leading NCDs and COVID-19 constitutes its own health emergency, and requires urgent attention. First, there needs to be an even greater focus on preventing community transmission in higher-risk populations. As the JAMA study shows, reducing the number of COVID-19 cases will also reduce the number of people with myocarditis after the pandemic has passed.

Governments and their partners in civil society must step up their efforts to prevent the virus from spreading in the first place. Public-health officials and media outlets should continue to emphasize the importance of wearing face masks, washing hands frequently with soap and running water, using hand sanitizer in the absence of clean water, and practicing social distancing of at least six feet (two meters) in public. If everyone were to adopt these practices, the number of new COVID-19 cases would likely fall dramatically, as would the number of people facing heart complications in the near future.

When the heart is inflamed, its ability to pump blood is reduced, and it may beat irregularly.

Image: JAMA

Furthermore, public-health authorities need to start devising interventions to provide lifelong cardiovascular support to COVID-19 survivors. Given the new data on heart-related complications, the broader pandemic response must include provisions for continuing care. Although such interventions may require the reallocation or reprioritization of existing resources, they would almost certainly be cost-effective when weighed against the costs of not addressing the additional NCD burden.

In fact, more attention should be focused on reducing the impact of NCDs more generally. The UKs experience offers lessons here. In 2018, the Scottish Shetlands authorized doctors to prescribe interactions with nature (hiking, bird watching, and so forth) as a means of preventing and managing NCDs. Similarly, the British government has pushed physicians to prescribe cycling as a way to address obesity. And through its Better Health Campaign, public service announcements encouraging weight loss, healthier eating, and physical activity will be running on television, radio, social media, and other channels. All countries with high rates of obesity should be considering similar programs.

Finally, the latest science points to the need for better geriatric care. The elderly are at increased risk of both NCDs and more severe complications from COVID-19. An analysis in July by the Kaiser Family Foundation shows that 80% of those who had died of COVID-19 in the US up to that point were 65 or older. Applying that rate to the US death toll as of August 21, it follows that around 139,500 of the 174,442 deceased have been elderly.

Meanwhile, more than three million Americans have now recovered from the virus, and among them are elderly survivors and other high-risk individuals who will need additional care, including home services. In Nigeria, the health-tech platform GeroCare provides affordable care to the elderly in the comfort of their homes through regular doctor visits. Its least expensive plan offers three home visits per month for just $50.

This approach to care needs to be scaled up significantly. The more we can reduce the heart-related and other complications of COVID-19, the more lives we will save.

See the article here:
COVID-19 survivors could suffer from heart inflammation, new study finds - World Economic Forum

Read More..

Researchers looked in to the effect of transport distance on commercial broiler chickens at distances of 15 km to 90 km.

Research conducted in Brazil evaluated the temperature, relative humidity and ECI-enthalpy comfort index of commercial loads of broiler chickens at distances of 15 km and 90 km in the summer and winter (rainy and dry) seasons and their effects on body weight difference, mortality and bruising prevalence.

Standard cargo bay used to transport broilers in this study. Photo: Research journal, PLOS ONE

Long-term water and feed deprivation have been correlated with yield losses at slaughter, and factors related to the vehicle, such as vibration, impact and road noise, also represent considerable sources of stress with consequent losses of yield parameters. In addition, variations in climatic conditions during transport, such as changes in temperature, relative humidity and air flow inside the cargo bay, are important stressors for broilers.

The consequences of microclimatic factors are almost always described as a function of broiler performance at slaughter, such as carcass yield (quantity of meat) and carcass quality (such as the presence of bruises). These analyses also considered and evaluated the degree of compromise of the thermal comfort of broiler chickens during transportation. This, said the researchers, could be used as a criterion for choosing and improving common practices during pre-slaughter handling, such as the critical time for catching and loading, determination of the density of broilers per crate, and wetting of the cargo.

The objective of this study was therefore to evaluate the microclimate of commercial shipments of broiler chickens transported over different distances during the rainy and dry seasons and the effect of microclimate on slaughter weight, body weight loss, mortality rate and occurrence of bruises on broiler carcasses considering the crate position.

In terms of comfort, the rainy season was the most critical period for broiler transport, resulting in the highest ECI. For example, in the rainy season and at a distance of 90km, the highest ECI was ranked in the lethal zone. Broiler chickens presented a higher body weight difference when transported over longer distances but crate positions with higher ECI in the load did not reflect significant body weight loss and mortality.

Thus, load microclimate can compromise broiler chicken welfare without necessarily impair broiler productivity. The prevalence of bruising on carcasses was not affected by the interaction between season and distance. Possibly, this prevalence can be associated with the management of the broilers during the breeding period. Broiler chicken performance, during transport, can also be related to road conditions, being hard to evaluate the actual impact of seasons and distances on animal welfare.

This study was published in PLOS ONE.

Read more:
Effect of transport distance and climate on broilers - Poultry World

Read More..

Young people with chronic health conditions cope with all of the usual challenges of growing up making friends, changing schools, adapting to new situations, developing a sense of self, and dealing with interpersonal conflict. But they also have to deal with the challenges of their illness.

Young people with inflammatory bowel disease (IBD), a group of chronic conditions that includes Crohns disease and ulcerative colitis, have to deal with unpleasant symptoms, intrusive treatment and uncertainty. Typical symptoms include diarrhoea, abdominal pain, weight loss, blood in their stools and fatigue. The disease can go into remission, but there is no cure and flare-ups can result in hospital stays and missing school or work.

Findings from our recent study on mental health among young people with IBD show that when experiencing symptoms, some young people feel negatively about their friendships because they are embarrassed about their condition. And we found that this can lead to loneliness along with depression and anxiety.

Many young people with IBD choose to conceal their diagnosis from friends and colleagues. Our study found this is often out of a desire to present themselves as normal along with wanting to keep health issues private for fear of being judged.

Read more: Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities

Being diagnosed with IBD can create an abrupt shift in a young persons expected biography, derailing their plans and expectations of life. Challenges to our identity are difficult to manage at any age, but can be particularly hard for young people as they transition towards adulthood.

Some young people we talked to said they feared being stigmatised because of their condition which has been shown to happen to adults with IBD. This can be a key concern for young people with IBD, particularly just after diagnosis and during major life transitions such as moving schools, going to university, or starting a job.

In our study, all of the young people had told at least one friend something about their IBD. Mostly their decision to tell had been their choice. But, visible indicators of their condition, such as a nasogastric tube, meant several young people felt compelled to disclose.

For such long-term chronic conditions, disclosure is ongoing and young people must make decisions throughout their life about what to disclose (or not) as they meet new people and enter into new situations. And although the social taboo of talking about bowels is being challenged, there is still a strong sense that toilet habits are awkward to talk about.

Starting a conversation about IBD was described as tricky and young people had to judge who they could trust typically close friends and how much to share. They generally avoided going into too much detail, or making a big a thing about it but also wanted friends to know it isnt just an upset stomach as one young woman explained:

Its hard to explain colitis, its the hardest thing in the world, still now after so many years. Its not just an upset tummy, its the whole body and lots more complications and medication.

Some young people told stories of negative reactions from friends arising from misconceptions about IBD. Some friends worried they could catch IBD. Others were scared by the word disease or did not want to be friends with someone who was different to them. Some young peoples friendships were severed. Yet many found their friends to be supportive and their friendship ties strengthened.

By talking about their experiences and sharing images of previously hidden aspects of treatment such as their stoma bag young people are breaking down taboos and reducing the sense of isolation that can come with having a chronic health condition.

But while challenging social stigma is essential, our study also shows how important it is for young people with IBD to look after their mental wellbeing and friendships can be a key part of this. This is why weve worked with young people to come up with the telling my friends resources, that will hopefully help other young people with Crohns or colitis talk to their friends about their condition.

Its also important to highlight that our findings show that despite the struggles young people with IBD experience, none of them wanted to be or felt defined by their condition. They have the same concerns, aspirations and desires as other young people, and ultimately just want to be seen as normal whatever that might look like.

Read this article:
'I don't want my friends to know' young people on growing up with Crohn's or colitis - The Conversation UK

Read More..

Testosterone Replacement Therapy Market 2018: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2024

The report provides both quantitative and qualitative information of global Testosterone Replacement Therapy market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Testosterone Replacement Therapy is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Testosterone Replacement Therapy market was valued at USD _ million/billion.

This research report based on Testosterone Replacement Therapy market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Testosterone Replacement Therapy market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Testosterone Replacement Therapy industry.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2643091&source=atm

Testosterone Replacement Therapy Market Overview:

The Research projects that the Testosterone Replacement Therapy market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

Leading manufacturers of Testosterone Replacement Therapy Market:

Competition AnalysisIn the competitive analysis section of the report, leading as well as prominent players of the global Testosterone Replacement Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testosterone Replacement Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testosterone Replacement Therapy market.The following manufacturers are covered in this report:AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus PharmaceuticalsTestosterone Replacement Therapy Breakdown Data by TypeGelsInjectionsPatchesOtherTestosterone Replacement Therapy Breakdown Data by ApplicationHospitalsClinicsOthers

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2643091&source=atm

Some important highlights from the report include:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2643091&licType=S&source=atm

The Questions Answered by Testosterone Replacement Therapy Market Report:

And Many More.

Read the original here:
Testosterone Replacement Therapy Projected to Witness Vigorous Expansion by 2019-2026 - The Daily Chronicle

Read More..

Lifting weights does a lot of things for women, but not among them is "bulk up."

Let's clear up one myth that runs rampant in the fitness industry: Women will not "bulk up" if they lift weights -- even heavy ones! People often use the term "bulky" in a negative way to describe others, typically women, who have large muscles or well-defined physiques.

As weightlifting gained popularity and edged its way into mainstream culture, many women developed a fear of turning into Arnold Schwarzenegger if they so much as touched a 10-pound dumbbell.

Marketing masterminds caught on and someone, somewhere invented the terms "lean muscle" and "tone up" to target women who wanted to exercise but not get "buff."

Our Health & Wellness newsletter puts the best products, updates and advice in your inbox.

We need to nix all of these terms from the fitness vernacular because first, women won't bulk up if they start lifting weights; second, lifting weights produces so many health benefits; and third, it's blatantly sexist to think women shouldn't look muscular anyway.

Here are four reasons to stop believing that strength training makes women bulky, plus several reasons to add weightlifting to your workout routine stat.

Now playing: Watch this: Amazon's Halo takes fitness tracking to new and uncomfortable...

7:07

This is good news for some, bad news for others -- it's great news for women who are afraid of packing on too much muscle. Building muscle is a long, slow process that requires years of consistency, dedication and effort.

Most people don't put in enough time or effort to create the kinds of physiques they're scared of. It takes several years to put on the kind of mass that bodybuilders have, and there's a reason professional bodybuilders are an elite few: They put in work that most people won't.

Real-life case in point: I've been lifting weights for more than seven years and I wouldn't call myself "bulky."

In general, womendon't produce as much testosterone as men. Testosterone production is a huge factor in your capacity for muscle growth, so this should automatically tell you that you won't turn into Wolverine overnight.

Of course, there are always exceptions: Some women have higher testosterone levels than other women, but even those with higher-than-average testosterone likely don't have enough to produce bulky muscles.

To build muscle, you must eat more calories than you burn. You can't grow new tissue out of nothing, so don't expect muscle growth if you're eating in a calorie deficit or even at maintenance. Many women don't eat enough calories or enough protein to support significant muscle growth.

For reference, the recommended calorie intake for a healthy woman is between 1,800 and 2,400 calories. If you exercise, you probably need to meet the higher end of that range, and potentially more if you're tall or very active. Unless you're eating more than your maintenance intake each day, don't worry about getting bulky.

Packing on a lot of muscle takes more calories, more protein and more testosterone than you might think.

Muscles don't grow in response to tasks they're used to. Your muscles need a challenge: If you're not progressively overloading your lifts on a regular basis, you're not encouraging your muscles to grow. They have no reason to get bigger if there is no demand.

To add more muscle mass, you need follow two primary rules with your workouts:

What's more is that those two techniques only work for so long -- eventually, as you get stronger, you'll also need to add in techniques like drop sets, super sets, pyramid sets and repping to failure to send stronger muscle-building signals to your brain.

Frequency is another key factor in building muscle. Studies show that when you train a muscle more often, it grows more in a shorter period of time. As with volume, however, there are caps on this concept. The stronger and fitter you get, the less of an impact frequency has on muscle growth.

Women who lift weights won't get bulky. They'll get strong, healthy, and probably more confident.

Women won't bulk up when they start lifting weights. What they will do, though, is lose body fat and earn the "toned" appearance so many people are after. Beyond aesthetics, women who lift weights will experience the numerous health benefits of resistance training.

Lifting weights can:

If those reasons aren't enough to pick up a pair of dumbbells, I don't know what is.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Read the original:
Does lifting weights make women bulky? The myth that won't die - CNET

Read More..

Advances in imaging have made assessment of atherosclerosis non-invasive, while the EVAPORATE trial demonstrates how cardiac CT can assist in looking at a host of different therapies, said Matthew Budoff, MD, professor of medicine at the David Geffen School of Medicine at UCLA and investigator at The Lundquist Institute.

Transcript:

The American Journal of Managed Care (AJMC):In EVAPORATE the only secondary endpoint which did not achieve a significant difference between control and intervention groups was dense calcium. What might account for this?

Dr. Budoff: Calcification is probably the last of the stages of atherosclerosis, so it's the least modifiable. So we saw low attenuation plaque, the vulnerable, or necrotic, core changed a lot, fibrofatty plaque, the softer plaque, changed moderately and fibrous plaque change less and then calcified plaque change the least. So I think that actually makes sense from a biological mechanism, that the most earliest plaques and the most vulnerable plaques changed the most, and the more stable plaques, like those with a lot of fibrous tissue or those with dense calcium, changed less. The P-value for calcification in multivariate analysis was .0531. So, you know, from a purist standpoint, it didn't change significantly. But some people would say .053 is pretty close to .05 and is close to statistical significance. But either way, I think it makes sense biologically that the more stable plaque changes less than the earlier softer plaques.

AJMC: As reduction of triglycerides on its own is not producing the dramatic drop in CV events, what are your thoughts on expanding the scope of patients receiving icosapent ethyl (Vascepa)?

Dr. Budoff: While I agree that triglyceride lowering isn't the primary benefit, I think those with high triglycerides are still a potential target. We have a number of populations where the target population is based on an abnormality of something, but we don't always treat that specific thing. For many years, diabetes, for example, the presence of diabetes meant your high cardiovascular risk and the treatment wasn't control the Hemoglobin A1c, the treatment was add other therapies. I think we still should be using icosapent ethyl largely in patients who have elevated triglycerides because that's where the benefit was shown to be the greatest. We have data now from triglycerides of 135 and up, and this group is still high risk. I want to emphasize that patients with elevated triglycerides, maybe because of metabolic syndrome and diabetes, and other factors, patients with elevated triglycerides are high risk, and they appear to benefit from icosapent ethyl. Whether it works in patients with normal triglycerides, I think that does deserve further study. We could not address that in EVAPORATE, because we did the EVAPORATE trial the same as the REDUCE IT study, and both of them used entry criteria for triglycerides of 135 and up.

AJMC: Do you have any final thoughts you would like to share?

Dr. Budoff: Well, I just wanted to point out that the use of cardiac CT now has become highly reproducible. The reduction in radiation dose does allow us to do these type of trials, where we can do serial studies and assess does drug A do better than drug B, or does drug A do better than placebo over time .We've had some early studies looking at statins with this serial CT angiography and we've published on the testosterone, that testosterone increases atherosclerosis plaque in our placebo controlled randomized trial. Now we've been able to show that icosapent ethyl reduces plaque. So I do think that it's a nice model. It's not invasive, it's easy, but I do think it's an important way to assess some of the benefits without having to do intravascular ultrasound, and take patients to the catheterization lab twice, with all of the associated risks.

I think the advances in imaging have made our assessment of atherosclerosis now non-invasive. And I think that's an important part of the message of EVAPORATE, that this is a potential tool to look at a host of different therapies that we now have. We're now doing a trial with GLP-1 receptor agonists with semaglutide to see if that slows plaque progression, because that's also shown outcome benefit without a clear mechanism of action.

See more here:
Dr Matthew Budoff on the Benefits of Cardiac CT Use - AJMC.com Managed Markets Network

Read More..

SARASOTA, Fla., Sept. 1, 2020 /PRNewswire/ --Transcendent Publishing today announced the release of Male 2.0: Cracking the Code to Limitless Health and Vitality by author Tracy Gapin, MD, FACS. Since its August release, the book has already reached Amazon bestseller status. Dr. Gapin, a men's health and performance expert and member of the American Urological Association, provides a meaningful impact for men's health with this leading-edge approach.

Over the past thirty years, there has been a relentless population-based decline in mens' testosterone levels by over thirty percent. We've also seen a dramatic increase in the incidence of obesity. Over seventy percent of men are either overweight or obese, which is directly tied to energy, productivity, and overall health and performance. This has led to a men's health epidemic for the 159 million men in the United States.

The Male Method described throughout Male 2.0 was developed to help men lose weight, regain energy, optimize their hormones, and regain peak performance. "We need to go beyond testosterone. We need to take an individualized, systems-based approach to optimize men's health, performance and longevity," says Tracy Gapin, MD, FACS. "Driven by the power of epigenetics, genetics, peptides, and wearable technologies, we have gained incredible insight into some of the most misunderstood aspects of men's health and longevity."

JJ Virgin, New York Times Bestselling author of The Virgin Diet & Sugar Impact Diet said, "As a thought leader in men's health, Dr. Gapin has provided the modern-day blueprint to help men optimize their health and regain their vitality. Every man should read this book."

Clete Walker, CEO of Vituro Health, a prostate health company, said, "Male 2.0 is a revolution for men's health. After my father was diagnosed with prostate cancer, I made it my mission to seek out potential new modalities, and this data-driven approach is the future."

Male 2.0: Cracking the Code to Limitless Health and Vitalityis available on Amazon and during the month of September the print version is available for free at The Gapin Institute. http://www.GapinInstitute.com

About Tracy Gapin, MD FACS:Dr. Gapin is board-certified Urologist, world renowned Men's Health & Performance Expert, Author, and Professional Speaker. Using state-of-the-art biometric monitoring, nutrition and lifestyle intervention, Dr. Gapin coaches Fortune 500 executives and evolutionary leaders of business, sports medicine, and high performance. He specializes in cutting-edge precision medicine with an emphasis on epigenetics, providing men with a personalized path to optimizing health & performance. http://www.GapinInstitute.comEmail: [emailprotected]

About Transcendent Publishing:Since 2012, Transcendent Publishing has specialized in offering a variety of publishing and design services for today's indie author. http://www.transcendentpublishing.com

CONTACT:Leann Spofford[emailprotected]Tel: (941) 524-4592

SOURCE Gapin Institute

Home – MMG

Link:
Men's Health Expert Tracy Gapin, MD Unveils Male 2.0 with a Revolutionary Protocol to Conquer the Men's Health Epidemic - PRNewswire

Read More..

Kevin Cash is likely facing a suspension, and Im okay with that.

Im okay with his overt threat to the Yankees because a manager must defend his players, and Im okay if Major League Baseball says that type of threat cannot be tolerated because this situation is rapidly growing dangerous.

Aroldis Chapman will almost certainly be suspended, and Im okay with that, too.

Its one thing to pitch up-and-in for effectiveness, its another thing to throw at a hitters torso to send a message, and its an entirely different world to throw a 101-mph fastball at someones head. Chapman must sit for a minimum of a week.

But Yankees manager Aaron Boone will likely skate free, and thats regrettable.

This bad blood between Tampa Bay and New York was arguably hastened by the Rays two years ago, but the Yankees have since acted like testosterone-fueled frat boys. And thats on Boone. As well as third base coach Phil Nevin, who has a history of being less-than-level-headed.

First, lets review what happened Tuesday night. Yankees starter Masahiro Tanaka, who has impeccable control, threw a pitch near Joey Wendles legs with two outs and nobody on in the first inning. On his next pitch, he drilled Wendle in the side with a 95-mph fastball, the hardest pitch he threw all night.

Was this retaliation for the Rays throwing up-and-in on D.J. LeMahieu the night before? Probably. Was it handled the right way by Tanaka? If you believe in old-school baseball justice then, yes, that was a proper response. And Cash seemed to say as much. So did Rays pitchers who did not try to hit any Yankees.

Then in the ninth inning, Chapman threw a 95-mph pitch high-and-tight on Wendle. He followed with a 99-mph pitch up-and-in on Austin Meadows. With two outs and nobody on, he uncorked a 101-mph pitch directly at the head of Mike Brosseau. The Rays infielder barely eluded the baseball as Chapman walked off the mound toward the plate.

The umpires huddled, decided to warn both benches, then automatically ejected Cash when he came out of the dugout to protest. Chapman eventually struck out Brosseau to end the game, then posed like a playground bully on the mound.

Brousseau was heading to the dugout when he clearly heard shouting from the Yankees side centerfielder Kevin Kiermaier specifically singled out Nevin for chirping and turned to say something himself. The benches emptied, but the confrontation ended quickly.

Then Cash unloaded in his postgame news conference.

Its absolutely ridiculous, he said. It was mishandled by the Yankees. Certainly, the pitcher on the mound. It was mishandled by the umpires. They hit Joey Wendle intentionally in the first inning. It was clear as day. Chapman comes in, he throws three different balls up and in. I get it they dont like being thrown up-and-in. But enoughs enough. Were talking about a 100-mph fastball over a young mans head.

Its poor judgment. Poor coaching. Its just poor teaching, what theyre doing, and what theyre allowing to do. The chirping from the dugout.

Had he stopped there, Cash would have been on solid ground. What followed was inflammatory, but also seemed purposeful. As if Cash knew he was risking suspension by drawing a line in the sand to force MLBs hand.

And the last thing Ill say on it is Ive got a whole damn stable full of guys that throw 98 mph. Period.

You could argue Cashs intent was understandable in a mutually-assured-destruction kind of way, but its hard to imagine MLB allowing a manager to threaten a beanball war, even if it was only a preemptive strike.

The umpires, who are supposed to be notified about previous altercations between teams, should have seen the situation for what it was, and immediately ejected Chapman and Boone. Their failure to act led to Cashs comments, and now will force MLB to step in today before somebody gets seriously hurt.

So how did we get here? The story is long and somewhat silly.

In September of 2018, the Rays hit Yankees with pitches in the first, second and third games of a series. The Yankees hit Rays in the second, third and fourth games of the series. After C.C. Sabathia hit Jake Bauers in that fourth game the third of four Rays he hit with a pitch that season Tampa Bays Andrew Kittredge threw near the head of Austin Romine.

It was a dangerous pitch and never should have been thrown. Kittredge was justifiably fined and suspended three games by the league. Sabathia, however, did not wait for official justice, and hit Jesus Sucre in the thigh later in the game. He was ejected, then pointed at the Rays dugout and shouted Thats for you, b---h, as he was leaving the field.

It could have ended there. It should have ended there.

Except the Yankees have continued to complain. And they seem to think every inside pitch is an affront to their glory.

The teams also exchanged taunts at Tropicana Field last month that stemmed from Nevins constant chirping. Every time a Rays pitcher got in trouble and was visited on the mound, Nevin could be heard shouting something to the effect of, Get him out of there.

When Yankees pitcher James Paxton gave up back-to-back home runs to tie the score in the seventh, it appeared Mike Zunino offered his own version of Get him out of there from the Rays dugout. The Yankees were not pleased.

Yet, from the time Sabathia walked off the mound in 2018, this has had the appearance of a one-sided feud.

Once again, there is a huge difference between pitching inside and headhunting. And there has been no indication that the Rays have tried to hit or hurt anyone in two years.

In fact, the Yankees have hit Rays batters 19 times since 2018. The Rays have hit 14 Yankees.

At this point, MLB needs to be involved. Someones career, even their life, could be jeopardized if this is allowed to escalate. And, frankly, Id be surprised if there was any intentional hit-by-pitches in Wednesdays game, considering the heightened attention.

And, just to be clear, the Rays are no choirboys in this episode, beginning with Kittredges pitch two years ago. But Tampa Bay took its punishment from Sabathia and MLB and seemed to move on.

As evidenced by Chapman last night, the Yankees have not.

John Romano can be reached at jromano@tampabay.com. Follow @romano_tbtimes.

See the article here:
This nonsense between the Yankees and Rays must stop. Immediately. - Tampa Bay Times

Read More..

Contact Us Today

Page 801«..1020..800801802803..810820..»

Home » Page 801